Published August 2016 | Version v1
Journal article

Unsolved mystery: the role of BRCA1 in DNA end-joining

  • 1. Department of Radiation Oncology, Division of Molecular Radiation Biology, University of Texas Southwestern Medical Center (United States)

Description

Heritable mutations in the tumor suppressor gene BRCA1 increase a woman's lifetime risk of developing breast and ovarian cancer. BRCA1's tumor suppressor function is directly linked to its myriad of functions in the cellular response to DNA double-strand breaks (DSBs). BRCA1 interacts with an extensive array of DNA damage responsive proteins and plays important roles in DSB repair, mediated by the homologous recombination pathway, and in the activation of cell cycle checkpoints. However, the role of BRCA1 in the other two DSB repair pathways, classical non-homologous end-joining (C-NHEJ) and alternative NHEJ (A-NHEJ), remains unclear. In this review, we will discuss the current literature on BRCA1's potential role(s) in modulating both C-NHEJ and A-NHEJ. We also present a model showing that BRCA1 contributes to genomic maintenance by promoting precise DNA repair across all cell cycle phases via the direct modulation of DNA end-joining

Availability note (English)

Available from http://dx.doi.org/10.1093/jrr/rrw032; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990114

Additional details

Publishing Information

Journal Title
Journal of Radiation Research
Journal Volume
57
Journal Issue
Suppl 1
Journal Page Range
p. 18-24
ISSN
0449-3060

INIS

Country of Publication
Japan
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47101992
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOLOGICAL PATHWAYS; CELL CYCLE; DNA REPAIR; GENE RECOMBINATION; MAMMARY GLANDS; NEOPLASMS; STRAND BREAKS
Descriptors DEC
BIOLOGICAL RECOVERY; BIOLOGICAL REPAIR; BODY; DISEASES; DNA DAMAGES; GLANDS; ORGANS; REPAIR

Optional Information

Copyright
Copyright (c) The Author 2016. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
Notes
PMCID: PMC4990114; PMID: 27170701; PUBLISHER-ID: rrw032; OAI: oai:pubmedcentral.nih.gov:4990114